PlainRecalls
FDA Drug Low Class III Ongoing

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

Reported: February 4, 2026 Initiated: December 15, 2025 #D-0300-2026

Product Description

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Units Affected
N/A
Distribution
US Nationwide.
Location
Piscataway, NJ

Frequently Asked Questions

What product was recalled?
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72. Recalled by NOVADOZ PHARMACEUTICALS LLC. Units affected: N/A.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on February 4, 2026. Severity: Low. Recall number: D-0300-2026.